Boston Beer Company's revenue growth is expected to slow down substantially, underperforming the wider industry. Despite this, the consensus price target remains unchanged, suggesting that the downgrades are not expected to have a long-term impact on the company's valuation.
RECAP The artificial intelligence mania that fueled the stock market to record highs this year was taking a breather Wednesday. Shares of chip makers were among those posting declines.$英偉達(NVDA.US)$shares were roughly flat. Stock indexes fell. The$標普500指數(.SPX.US)$fell 0.17%, while the$納斯達克綜合指數(.IXIC.US)$fell 0.55% and$道瓊斯指數(.DJI.US)$fell 0.06%. Benchmark$美國10年期國債收益率(US10Y.BD)$fell belo...
CFRA's Garrett Nelson downgraded the company's stock to Sell, predicting a drop to $275 within a year. UBS's Peter Grom kept a Neutral rating but reduced his price target to $355 from $390, citing doubts about near-term sales growth.
Morning Movers Gapping up $特斯拉(TSLA.US)$stock rose 0.3% after Chief Executive Elon Musk said the electric vehicle manufacturer had completed production design on a long-planned update to its Roadster electric sportscar, adding that it was likely to ship starting next year. $TJX公司(TJX.US)$stock rose 1.4% after the retailer topped market expectations for fourth-quarter sales on Wednesday as shoppers flocked to its T...
The stock seems overpriced compared to industry average. Despite its volatility and potential for price drop, the market has factored in the company's positive outlook. The stock's price surpasses its industry peers, suggesting it may not be the best time to buy.
Boston Beer Company's ROCE trend is disappointing, with diminishing returns despite business reinvestment. The stock's 5-year return to shareholders is only 30%, mirroring these poor trends. Investors seeking a multi-bagger might find better opportunities elsewhere.
Investors anticipate Boston Beer Company's sustained growth, justifying its high P/E ratio. The potential for earnings deterioration is not seen as significant enough to warrant a lower P/E ratio, providing strong share price support.
Constellation Brands had a weak quarter with underwhelming earnings guidance. Duckhorn showed the slowest revenue growth and weakest full-year guidance. Boston Beer and Zevia PBC had mixed quarters with misses and beats on various estimates.
Significant insider selling activities at Boston Beer Company over the last three months could be cause for investor concern. Despite the company's growth and profitability, the lack of insider purchases over the last year implies potential lack of confidence in the stock.
波斯頓啤酒股票討論區
The artificial intelligence mania that fueled the stock market to record highs this year was taking a breather Wednesday. Shares of chip makers were among those posting declines. $英偉達(NVDA.US)$ shares were roughly flat.
Stock indexes fell. The $標普500指數(.SPX.US)$ fell 0.17%, while the $納斯達克綜合指數(.IXIC.US)$ fell 0.55% and $道瓊斯指數(.DJI.US)$ fell 0.06%.
Benchmark $美國10年期國債收益率(US10Y.BD)$ fell belo...
Gapping up
$特斯拉(TSLA.US)$ stock rose 0.3% after Chief Executive Elon Musk said the electric vehicle manufacturer had completed production design on a long-planned update to its Roadster electric sportscar, adding that it was likely to ship starting next year.
$TJX公司(TJX.US)$ stock rose 1.4% after the retailer topped market expectations for fourth-quarter sales on Wednesday as shoppers flocked to its T...
5年來營收持續增長,平均增速19.3%,營業利潤受毛利率下滑影響很大,2020年達到高點後大幅萎縮,5年來大幅波動中沒什麼增長,淨利潤5年來反而有所萎縮。沒有利息負擔。毛利率近5年來從51.5%下降到41.2%,2022年淨資產收益率6.6%,2021年之前3年基本在20%左右。
2023前3季度營收萎縮1.7%,營業利潤增長3.5%,淨利潤受資產減值收窄影響增長了20%。
目前市盈率65.3,市盈率TTM52.6,估值明顯過高,缺乏吸引力。
暫無評論